(Press-News.org) ST. PAUL, Minn. – A new study shows that vitamin B12 may protect against Alzheimer's disease, adding more evidence to the scientific debate about whether the vitamin is effective in reducing the risk of memory loss. The research will be published in the October 19, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.
"Our findings show the need for further research on the role of vitamin B12 as a marker for identifying people who are at increased risk of Alzheimer's disease," said study author Babak Hooshmand, MD, MSc, with Karolinska Institutet in Stockholm, Sweden. "Low levels of vitamin B12 are surprisingly common in the elderly. However, the few studies that have investigated the usefulness of vitamin B12 supplements to reduce the risk of memory loss have had mixed results."
For the seven-year study, researchers took blood samples from 271 Finnish people age 65 to 79 who did not have dementia at the start of the study. During that time, 17 people developed Alzheimer's disease. Blood samples were tested for levels for homocysteine, an amino acid associated with vitamin B12, and for levels of the active portion of the vitamin, called holotranscobalamin. Too much homocysteine in the blood has been linked to negative effects on the brain, such as stroke. However, higher levels of vitamin B12 can lower homocysteine.
The study found that for each micromolar increase in the concentration of homocysteine, the risk of Alzheimer's disease increased by 16 percent, whereas each picomolar increase in concentration of the active form of vitamin B12 reduced risk by two percent. The results stayed the same after taking into account other factors, such as age, gender, education, smoking status, blood pressure and body mass index. The addition of folate did not appear to raise or lower the risk of Alzheimer's disease.
"More research is needed to confirm these findings before vitamin B12 should be used solely as a supplement to help protect memory," said Hooshmand.
INFORMATION:
Vitamin B12 can be found in fish, poultry and other meat products.
The study was supported by the Karolinska Institutet, the Swedish Research Council for Medical Research, the European Commission Seventh Framework Programme, the Academy of Finland, the Ragnhild and Einar Lundströms Minne Lindhés Foundation, the Stohnes Foundation, the Gamla Tjanarinnor Foundation and the Dementia Foundation of Sweden.
The American Academy of Neurology, an association of more than 22,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington's disease, and dementia.
For more information about the American Academy of Neurology, visit http://www.aan.com.
VIDEO: http://www.youtube.com/AANChannel
TEXT: http://www.aan.com/press
TWEETS: http://www.twitter.com/AANPublic
Vitamin B12 may reduce risk of Alzheimer's disease
2010-10-19
ELSE PRESS RELEASES FROM THIS DATE:
Soy intake associated with lower recurrence of breast cancer in hormone-sensitive cancers
2010-10-19
Post-menopausal breast cancer patients with hormone-sensitive cancers who consumed high amounts of soy isoflavones had a lower risk of recurrence, found a research study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091298.pdf.
Soy isoflavones are similar to estrogen in chemical structure and may stimulate or inhibit estrogen-like action in tissues. Consumption of soy isoflavones, found in soybeans and soy products, has increased in recent years and there are concerns about the effect of soy consumption ...
Analysis indicates a third H1N1 pandemic wave unlikely in 2010
2010-10-19
Analysis of H1N1 antibody levels (seroprotection rates) after the 2009 pandemic suggest that a third wave is unlikely in 2010, although adults over age 50, particularly those with chronic conditions, should be immunized for the fall flu season, states a research paper in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100910.pdf.
The study, by researchers from the BC Centre for Disease Control, University of British Columbia and BC Biomedical Laboratories, compared blood levels of antibodies against the H1N1 influenza ...
Lessons learned from the H1N1 pandemic
2010-10-19
The H1N1 pandemic influenza provided several important lessons that may help in preparing for future influenza outbreaks, write Drs. Donald Low and Allison McGeer in an analysis in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100900.pdf.
Although the death rate was lower than initially projected, the years of life lost was significant because "deaths from the 2009 pandemic were skewed toward younger ages than deaths from seasonal influenza," write the authors, both affiliated with Mount Sinai Hospital and the University ...
Tackling cognitive deficits in Alzheimer's disease: 1 'STEP' at a time
2010-10-19
Lowering levels of a key protein involved in regulating learning and memory—STtriatal-Enriched tyrosine Phosphatase (STEP)—reversed cognitive deficits in mice with Alzheimer's disease, Yale School of Medicine researchers report in the October 18 issue of Proceedings of the National Academy of Sciences.
"This finding provides a rationale for drug discovery and for developing therapeutic agents that could inhibit STEP proteins and might improve the outlook for Alzheimer's disease patients," said senior author of the study Paul Lombroso, M.D., professor in the Yale Child ...
Beta carotene and retinitis pigmentosa
2010-10-19
CHICAGO—Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meeting–the world's largest, most comprehensive ophthalmic education conference–is in session October 16 through 19 at McCormick Place, Chicago.
9-cis Beta-Carotene Mat Boost Vision in Some Patients with Incurable Retinal Disease Retinitis pigmentosa (RP) is a cluster of hereditary disorders ...
New evidence of the power of open access
2010-10-19
New findings settle one of the arguments about Open Access (OA) research publications: Are they more likely to be cited because they were made OA, or were they made OA because they were more likely to be cited?
The study, which will be published in PLoS ONE on the first day of Open Access Week (18 October), was carried out by a bi-national team of researchers from the University of Southampton's School of Electronics and Computer Science (ECS) in the UK and l'Université du Québec à Montréal in Canada.
The results show that the OA citation impact advantage is just ...
Surgical complications drop at hospitals that share patient safety data
2010-10-19
ANN ARBOR, Mich. – Michigan hospitals reduced surgical complications by nearly 10 percent at a time when the rest of the nation saw no change in complication rates, according to a new study out next week in the Archives of Surgery.
Complications dropped at hospitals participating in what's called the Michigan Surgical Quality Collaborative, a group of 16 hospitals led by the University of Michigan Health System that agreed to pool data and share information about what keeps patients safe.
The fewer patients suffering ventilator associated pneumonias alone, among the ...
News and insights in gastroenterology presented at the ACG's 75th Annual Meeting
2010-10-19
Bethesda, Maryland (October 14, 2010) – Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.
Innovative technologies for the diagnosis and treatment of digestive diseases; insights into digestive health conditions, their causes and how they impact ...
Allergy drug found to clear condition but not symptoms of throat disease
2010-10-19
ROCHESTER, Minn. -- A group of Mayo Clinic (http://www.mayoclinic.org/about/) researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis (http://www.mayoclinic.org/eosinophilic-esophagitis/). Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology ...
The protein NOS2 isn't good for ER-negative breast cancer patients
2010-10-19
Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast cancer are urgently needed. Now, a team of researchers, led by Stefan Ambs, at the ...